Job Description
Overview
Fusion Pharmaceuticals, a member of the AstraZeneca Group, is a clinical-stage oncology company focused on developing next-generation radioconjugates (RCs) as precision medicines. Fusion connects alpha particle emitting isotopes to various targeting molecules to selectively deliver the alpha emitting payloads to tumors. Fusion’s clinical portfolio includes: FPI-2265 targeting PSMA for metastatic castration resistant prostate cancer currently in a Phase 2 trial; FPI-1434 targeting IGF-1 receptor currently in a Phase 1 trial; FPI-2059, a small molecule targeting NTSR1, currently in a Phase 1 trial; and FPI-2068, a bispecific IgG-based EGFR-cMET targeted radioconjugate currently in a Phase 1 trial. In addition, Fusion is pursuing combination programs between RCs and DDR inhibitors and immune-oncology agents. Fusion has a fully operational GMP compliant radiopharmaceutical manufacturing facility to meet supply demand for Fusion’s growing pipeline of RCs.
The ...
Apply for this Job
Submit your application for the Scientist, Radiochemistry position at AstraZeneca.
Apply Now Save for Later